It's Flu Season — 14 Products to Keep on Hand, According to a Nurse
As a nurse, I’ve seen how the virus can cause serious health complications. Check out the following items to keep on hand to ...
Resyca Receives Medical Device Regulation Certificate From TÜV SÜD
MDR Certification Strengthens Resyca’s Leadership in Soft Mist Drug-Device Combination Products ENSCHEDE, NL / ACCESS ...
Milestone Pharmaceuticals Provides 2025 Corporate Outlook and Will Host Investor Event on February 25 in NYC
PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT)- Commercial capabilities ...
Yahoo Finance1d
Milestone Pharmaceuticals Inc. (MIST)
PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular ... Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused ...
Milestone Pharmaceuticals Inc.: Milestone Pharmaceuticals Provides 2025 Corporate Outlook and Will Host Investor Event on February 25 in NYC
PDUFA date of March 27, 2025 for CARDAMYST (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT) - Commercial capabilities build out in process, with proposed launch in PSVT targe ...
Stock up on these cold and flu survival must-haves before you get sick — they’re doctor-approved
Doctors shared their must-have sick season buys with The Post, revealing which medicines, supplements and tools you should ...
WJCL6d
South Carolina health officials confirm first child death of the flu season
The South Carolina Department of Public Health announced Friday that the state has suffered its first pediatric flu-related death of the season.
H.C. Wainwright maintains $25 target on Milestone shares
H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating and a price target of $25.00 on Milestone Pharmaceuticals, traded on NASDAQ under the ticker (NASDAQ:MIST). The stock has shown strong ...
14 key things parents should know about RSV in 2025: Symptoms, treatment & prevention
As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, with health experts warning ...